litlas
ログインアカウント作成

Suling Liu

2005–2024 年に発表

85
論文数
18,475
被引用数
54
h 指数
80
i10 指数

被引用数

Suling Liu の年別被引用数2002 年: 被引用 2 件2004 年: 被引用 1 件2005 年: 被引用 3 件2006 年: 被引用 35 件2007 年: 被引用 89 件2008 年: 被引用 152 件2009 年: 被引用 150 件2010 年: 被引用 215 件2011 年: 被引用 275 件2012 年: 被引用 285 件2013 年: 被引用 318 件2014 年: 被引用 276 件2015 年: 被引用 312 件2016 年: 被引用 267 件2017 年: 被引用 222 件2018 年: 被引用 210 件2019 年: 被引用 768 件2020 年: 被引用 746 件2021 年: 被引用 710 件2022 年: 被引用 554 件2023 年: 被引用 479 件2024 年: 被引用 733 件2025 年: 被引用 375 件2026 年: 被引用 12 件2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,064 件、この内訳の 25.1%中国: 引用元論文 1,870 件、この内訳の 22.7%イギリス: 引用元論文 362 件、この内訳の 4.4%イタリア: 引用元論文 333 件、この内訳の 4%インド: 引用元論文 296 件、この内訳の 3.6%ドイツ: 引用元論文 266 件、この内訳の 3.2%カナダ: 引用元論文 206 件、この内訳の 2.5%韓国: 引用元論文 197 件、この内訳の 2.4%スペイン: 引用元論文 193 件、この内訳の 2.3%オーストラリア: 引用元論文 179 件、この内訳の 2.2%フランス: 引用元論文 179 件、この内訳の 2.2%日本: 引用元論文 179 件、この内訳の 2.2%
0%25.1%その他 23.2%

機関

分野

  • Medicine49.8%
  • Biochemistry, Genetics and Molecular Biology39.6%
  • Immunology and Microbiology4.7%
  • Engineering1.6%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Agricultural and Biological Sciences0.7%
  • その他2.6%

トピック

  • Cancer Cells and Metastasis13.7%
  • Epigenetics and DNA Methylation4.5%
  • Cancer, Hypoxia, and Metabolism3.4%
  • MicroRNA in disease regulation2.3%
  • Immune cells in cancer2.2%
  • Cancer-related molecular mechanisms research2.2%
  • その他71.7%

共著者

全論文

検索で開く
  1. ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

    著者: Christophe Ginestier, Min Hee Hur, Emmanuelle Charafe‐Jauffret, Florence Monville, Julie Dutcher, Marty Brown, Jocelyne Jacquemier, Patrice Viens, Celina G. Kleer, Suling Liu, Anne F. Schott, Daniel Hayes, Daniel Birnbaum, Max S. Wicha, Gabriela Dontu - Cell stem cell 2007 被引用: 3,991

  2. Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

    著者: Suling Liu, Yang Cong, Dong Wang, Yu Sun, Lu Deng, Yajing Liu, Rachel Martin-Trevino, Shang Li, Sean McDermott, Melissa D. Landis, Su‐Hyung Hong, April Adams, Rosemarie C. D'Angelo, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Shawn G. Clouthier, Daniel Birnbaum, Stephen T.C. Wong, Ming Zhan, Jenny Chia-Chen Chang, Max S. Wicha - Stem Cell Reports 2014 被引用: 1,066

  3. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells

    著者: Bai Cui, Yuanyuan Luo, Pengfei Tian, Fei Peng, Jinxin Lü, Yongliang Yang, Qitong Su, Bing Liu, Jiachuan Yu, Xudong Luo, Yin Liu, Wei Cheng, Fan An, Bin He, Dapeng Liang, Sijin Wu, Peng Chu, Luyao Song, Xinyu Liu, Huandong Luo, Jie Xu, Yujia Pan, Yang Wang, Dangsheng Li, Peng Huang, Qingkai Yang, Lingqiang Zhang, Binhua P. Zhou, Suling Liu, Guowang Xu, Eric W.‐F. Lam, Keith W. Kelley, Quentin Liu - Journal of Clinical Investigation 2019 被引用: 321

  4. Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis

    著者: Mingming Wu, Xiao Zhang, Weijie Zhang, Yi‐Shiou Chiou, Wenchang Qian, Xiangtian Liu, Min Zhang, Hong Yan, Shilan Li, Tao Li, Xinghua Han, Pengxu Qian, Suling Liu, Yueyin Pan, Peter E. Lobie, Tao Zhu - Nature Communications 2022 被引用: 179

  5. ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

    著者: Cuicui Liu, Jiankun Qiang, Qiaodan Deng, Jie Xia, Lu Deng, Lei Zhou, Dong Wang, Xueyan He, Ying Liu, Botao Zhao, Jinhui Lv, Zuoren Yu, Qun-Ying Lei, Zhi-Ming Shao, Xiao-Yong Zhang, Lixing Zhang, Suling Liu - Cancer Research 2021 被引用: 172

  6. Targeting Breast Cancer Stem Cells

    著者: Lu Zhang, Wen‐Ming Chen, Suling Liu, Ceshi Chen - International Journal of Biological Sciences 2023 被引用: 168

  7. PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer

    著者: Ying Wu, Zhe Wang, Lu Han, Zhihao Guo, Bohua Yan, Lili Guo, Huadong Zhao, Mengying Wei, Niuniu Hou, Jing Ye, Zhe Wang, Changhong Shi, Suling Liu, Ceshi Chen, Suning Chen, Ting Wang, Jun Yi, Jianping Zhou, Libo Yao, Wenxia Zhou, Rui Ling, Jian Zhang - Molecular Therapy 2022 被引用: 123

  8. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway

    著者: Rui Zhang, Mengxue Dong, Juchuanli Tu, Fengkai Li, Qiaodan Deng, Jiahui Xu, Xue‐Yan He, Jiajun Ding, Jie Xia, Dandan Sheng, Zhaoxia Chang, Wei Ma, Haonan Dong, Yi Zhang, Lixing Zhang, Lu Zhang, Suling Liu, Lu Zhang, Suling Liu - Signal Transduction and Targeted Therapy 2023 被引用: 120

  9. Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

    著者: Hasan Körkaya, Gwang-il Kim, April Davis, Fayaz Malik, N. Lynn Henry, Suthinee Ithimakin, Ahmed A. Quraishi, Nader Tawakkol, Rosemarie C. D'Angelo, Amanda K. Paulson, Susan Chung, Tahra Luther, Hayley J. Paholak, Suling Liu, Khaled A. Hassan, Qin Zen, Shawn G. Clouthier, Max S. Wicha - Molecular Cell 2012 被引用: 539

  10. Breast cancer stem cells, cytokine networks, and the tumor microenvironment

    著者: Hasan Körkaya, Suling Liu, Max S. Wicha - Journal of Clinical Investigation 2011 被引用: 609

  11. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity

    著者: Rui Zhang, Juchuanli Tu, Suling Liu - Seminars in Cancer Biology 2021 被引用: 84

  12. Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells

    著者: Yanyan Li, Tao Zhang, Hasan Körkaya, Suling Liu, Hsiu-Fang Lee, Bryan Newman, Yanke Yu, Shawn G. Clouthier, Steven J. Schwartz, Max S. Wicha, Duxin Sun - Clinical Cancer Research 2010 被引用: 565

  13. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization

    著者: Dandan Sheng, Wei Ma, Rui Zhang, Lei Zhou, Qiaodan Deng, Juchuanli Tu, Weilong Chen, Fuchuang Zhang, Nailong Gao, Mengxue Dong, Dong Wang, Fengkai Li, Yin Liu, Xue‐Yan He, Sheng‐Zhong Duan, Lixing Zhang, Tong Liu, Suling Liu - Journal for ImmunoTherapy of Cancer 2022 被引用: 76

  14. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

    著者: Jie Xia, Siqin Li, Suling Liu, Lixing Zhang - MedComm 2023 被引用: 72

  15. TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer

    著者: Jiahui Xu, Xiaoli Yang, Qiaodan Deng, Cong Yang, Dong Wang, Guojuan Jiang, Xiaohong Yao, Xueyan He, Jiajun Ding, Jiankun Qiang, Juchuanli Tu, Rui Zhang, Qun‐Ying Lei, Zhimin Shao, Xiu‐Wu Bian, Ronggui Hu, Lixing Zhang, Suling Liu - Nature Communications 2021 被引用: 72

  16. Novel Clinical mNGS-Based Machine Learning Model for Rapid Antimicrobial Susceptibility Testing of Acinetobacter baumannii

    著者: Xuejiao Hu, Yunhu Zhao, Peng Han, Suling Liu, Weijiang Liu, Cong Mai, Qianyun Deng, Jing Ren, Jiajie Luo, Fangyuan Chen, Xuefeng Jia, Jing Zhang, Guanhua Rao, Bing Gu - Journal of Clinical Microbiology 2023 被引用: 52

  17. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity

    著者: Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yi‐Zhou Jiang, Hongqi Li, Zhiming Shao, Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yueyin Pan, Wei Jiang, Rongbin Zhou - Nature Cell Biology 2020 被引用: 108

  18. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance

    著者: Fei Chen, Qilai Long, Da Fu, Dexiang Zhu, Yanhui Ma, Liu Han, Boyi Zhang, Qixia Xu, Bingjie Liu-Lastres, Yan Li, Shanshan Wu, Yang Chen, Min Qian, Jianmin Xu, Suling Liu, Liu Cao, Y. Eugene Chin, Eric W.‐F. Lam, Jean‐Philippe Coppé, Yu Sun - Nature Communications 2018 被引用: 126

  19. Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks

    著者: Suling Liu, Christophe Ginestier, Sing J. Ou, Shawn G. Clouthier, Shivani Patel, Florence Monville, Hasan Körkaya, Amber Heath, Julie Dutcher, Celina G. Kleer, Younghun Jung, Gabriela Dontu, Russell S. Taichman, Max S. Wicha - Cancer Research 2011 被引用: 610

  20. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1

    著者: Wei Ma, Lu Zhang, Weilong Chen, Zhaoxia Chang, Juchuanli Tu, Yuanyuan Qin, Yuwen Yao, Mengxue Dong, Jiajun Ding, Siqin Li, Fengkai Li, Qiaodan Deng, Yifei Yang, Tingting Feng, Fanrong Zhang, Xiying Shao, Xueyan He, Lixing Zhang, Guohong Hu, Quentin Liu, Yi‐Zhou Jiang, Shu Zhu, Zhi Xiao, Dan Su, Tong Liu, Suling Liu, Tong Liu, Suling Liu - Protein & Cell 2024 被引用: 72

  21. Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy

    著者: Haonan Dong, Lu Zhang, Suling Liu - International Journal of Biological Sciences 2022 被引用: 61

  22. IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer

    著者: Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guohong Hu, Chong Liu, Yi‐Zhou Jiang, Zhi‐Ming Shao, Ceshi Chen, Suling Liu - Cancer Research 2024 被引用: 44

  23. Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells

    著者: Suling Liu, Gabriela Dontu, Ilia D. Mantle, Shivani Patel, Nam-shik Ahn, Kyle W. Jackson, Prerna Suri, Max S. Wicha - Cancer Research 2006 被引用: 1,229

  24. Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer

    著者: Qing Zhao, Xuexin He, Xiyi Qin, Yu Liu, Han Jiang, Jing Wang, Shuang Wu, Rui Zhou, Congcong Yu, Suling Liu, Hong Zhang, Mei Tian - Frontiers in Immunology 2022 被引用: 49